Display Settings:

Format

Send to:

Choose Destination
Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S95-9. doi: 10.1055/s-0029-1220218. Epub 2009 Apr 7.

[Value of general human papillomavirus vaccination in sexually active women].

[Article in German]

Author information

  • Frauenklinik der Universität Düsseldorf. hampl@med.uni-duesseldorf.de

Abstract

Most cervical cancers are caused by human papillomavirus (HPV) genotypes 16 or 18, while almost all the anogenital warts are related to HPV 6 and 11. In placebo-controlled trials, a vaccine against HPV (6, 11, 16, 18) almost completely prevented infections and associated clinical lesions in primarily not infected women. Furthermore, new data demonstrate that sexually active women, as well as those with prior infection, also benefit from the vaccine. These results suggest that a general vaccination programme for sexually active women will be beneficial.

PMID:
19353480
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Write to the Help Desk